Heavy-Drinking Smokers' Treatment Needs and Preferences: A Mixed-Methods Study

被引:9
|
作者
Fucito, Lisa M. [1 ,2 ,3 ]
Hanrahan, Tess H. [1 ]
机构
[1] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT 06511 USA
[2] Smilow Canc Hosp Yale New Haven, New Haven, CT 06519 USA
[3] Yale Univ, Ctr Canc, New Haven, CT 06510 USA
基金
美国国家卫生研究院;
关键词
Cigarette smoking; Heavy drinking; Smoking cessation; Treatment; Qualitative research; SMOKING-CESSATION; ALCOHOL-USE; CIGARETTE-SMOKING; TOBACCO SMOKING; CUE-REACTIVITY; NICOTINE; URGES; CONSUMPTION; RISK; METAANALYSIS;
D O I
10.1016/j.jsat.2015.07.001
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
The purpose of this mixed methods study was to describe the smoking and psychological characteristics of heavy-drinking smokers, their perceptions of smoking and drinking, and their smoking and alcohol treatment preferences to inform an integrated smoking and alcohol intervention. Heavy-drinking smokers (N = 26) completed standardized surveys and participated in semi-structured focus group interviews. Participants reported a strong association between their smoking and drinking. Participants were more motivated to quit smoking than to reduce their drinking but perceived greater barriers to smoking cessation. Stress/negative affect was closely linked with both behaviors. They expressed overall enthusiasm for a smoking and alcohol intervention but had specific format and content preferences. Half preferred an integrated treatment format whereas others preferred a sequential treatment model. The most preferred content included personalized health feedback and a way to monitor health gains after behavior changes. (C) 2015 Elsevier Inc. All rights reserved.
引用
收藏
页码:38 / 44
页数:7
相关论文
共 50 条
  • [1] Differential effects of naltrexone in heavy-drinking smokers and non-smokers
    Tidey, J
    Miranda, R
    Monti, P
    Rohsenow, D
    Swift, R
    Gwaltney, C
    McGeary, J
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 2004, 28 (05) : 113A - 113A
  • [2] Varenicline decreases alcohol consumption in heavy-drinking smokers
    Jennifer M. Mitchell
    Candice H. Teague
    Andrew S. Kayser
    Selena E. Bartlett
    Howard L. Fields
    [J]. Psychopharmacology, 2012, 223 : 299 - 306
  • [3] Varenicline decreases alcohol consumption in heavy-drinking smokers
    Mitchell, Jennifer M.
    Teague, Candice H.
    Kayser, Andrew S.
    Bartlett, Selena E.
    Fields, Howard L.
    [J]. PSYCHOPHARMACOLOGY, 2012, 223 (03) : 299 - 306
  • [4] Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
    Yardley, Megan M.
    Mirbaba, Michael M.
    Ray, Lara A.
    [J]. CNS DRUGS, 2015, 29 (10) : 833 - 845
  • [5] Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
    Megan M. Yardley
    Michael M. Mirbaba
    Lara A. Ray
    [J]. CNS Drugs, 2015, 29 : 833 - 845
  • [6] Combined varenicline and naltrexone treatment reduces smoking topography intensity in heavy-drinking smokers
    Roche, Daniel J. O.
    Bujarski, Spencer
    Hartwell, Emily
    Green, ReJoyce
    Ray, Lara A.
    [J]. PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2015, 134 : 92 - 98
  • [7] Dementia caregivers training needs and preferences for online interventions: A mixed-methods study
    Teles, Soraia
    Paul, Constanca
    Napolskij, Milaydis Sosa
    Ferreira, Ana
    [J]. JOURNAL OF CLINICAL NURSING, 2022, 31 (13-14) : 2036 - 2054
  • [8] An integrated behavioural intervention combined with varenicline for heavy-drinking smokers: a randomized pilot study
    Fucito, Lisa M.
    Wu, Ran
    O'Malley, Stephanie S.
    Hanrahan, Tess H.
    Ikomi, Jolomi T.
    Muvvala, Srinivas
    Carroll, Kathleen M.
    Gueorguieva, Ralitza
    [J]. JOURNAL OF SMOKING CESSATION, 2020, 15 (03) : 119 - 127
  • [9] Varenicline Reduces Alcohol Self-Administration in Heavy-Drinking Smokers
    McKee, Sherry A.
    Harrison, Emily L. R.
    O'Malley, Stephanie S.
    Krishnan-Sarin, Suchitra
    Shi, Julia
    Tetrault, Jeanette M.
    Picciotto, Marina R.
    Petrakis, Ismene L.
    Estevez, Naralys
    Balchunas, Erika
    [J]. BIOLOGICAL PSYCHIATRY, 2009, 66 (02) : 185 - 190
  • [10] Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings
    Ray, Lara A.
    Courtney, Kelly E.
    Ghahremani, Dara G.
    Miotto, Karen
    Brody, Arthur
    London, Edythe D.
    [J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2015, 41 (01): : 35 - 44